Renal Mass Biopsy—A Renaissance?
2007; Lippincott Williams & Wilkins; Volume: 179; Issue: 1 Linguagem: Inglês
10.1016/j.juro.2007.08.124
ISSN1527-3792
AutoresBrian R. Lane, Mary K. Samplaski, Brian R. Herts, Ming Zhou, Andrew C. Novick, Steven C. Campbell,
Tópico(s)Renal Diseases and Glomerulopathies
ResumoNo AccessJournal of UrologyReview article1 Jan 2008Renal Mass Biopsy—A Renaissance? Brian R. Lane, Mary K. Samplaski, Brian R. Herts, Ming Zhou, Andrew C. Novick, and Steven C. Campbell Brian R. LaneBrian R. Lane Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author , Mary K. SamplaskiMary K. Samplaski Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author , Brian R. HertsBrian R. Herts Department of Radiology, Cleveland Clinic, Cleveland, Ohio More articles by this author , Ming ZhouMing Zhou Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio More articles by this author , Andrew C. NovickAndrew C. Novick Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author , and Steven C. CampbellSteven C. Campbell Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2007.08.124AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Advances in our understanding of the natural history and limited aggressive potential of many small renal masses, expanding treatment options and the integration of molecular factors into prognostic and therapeutic algorithms have stimulated renewed interest in percutaneous renal mass biopsy. Materials and Methods: A comprehensive literature review was performed using MEDLINE®/PubMed® to evaluate the indications, techniques, complications and efficacy of renal mass biopsy. Results: Reported techniques of renal mass biopsy vary widely with different modes of radiographic guidance, needle size, number of cores and pathological analyses. Percutaneous renal mass biopsy with 2 or 3 cores using 18 gauge needles may improve diagnostic accuracy without increasing morbidity. Serious complications of percutaneous biopsy are rare and the minor complication rate in recent series has been less than 5%. The reported rate of technical failure of renal mass biopsy due to insufficient material was about 9% before 2001 and 5% in more recent studies. The likelihood of indeterminate or inaccurate pathological findings has decreased from 10% to 4% when comparing clinical studies before and since 2001. Currently a total success rate of greater than 90% is attainable using renal mass biopsy with standard histopathological analysis. Recent studies demonstrated that combining immunohistochemical and molecular analyses may further improve renal mass biopsy accuracy. Conclusions: Research on expanded analysis of percutaneous renal mass biopsy specimens should remain a top priority. Enhanced renal mass biopsy should not change treatment in most patients with small renal masses, who should be treated with surgical excision. However, future clinical algorithms will likely incorporate enhanced biopsy in situations in which decision making is more challenging. References 1 : Rising incidence of renal cell cancer in the United States. JAMA1999; 281: 1628. Crossref, Medline, Google Scholar 2 : Solid renal tumors: an analysis of pathological features related to tumor size. J Urol2003; 170: 2217. Link, Google Scholar 3 : A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol2007; 178: 429. Link, Google Scholar 4 : Classification of renal neoplasms based on molecular signatures. J Urol2006; 175: 2302. Link, Google Scholar 5 : Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol2003; 169: 71. Link, Google Scholar 6 : Aspiration biopsy of the kidney: Simultaneous collection of cytologic and histologic specimens. Cancer1985; 56: 200. Google Scholar 7 : Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology1997; 50: 25. Crossref, Medline, Google Scholar 8 : Diagnostic evaluation and initial staging work-up of women with suspected breast cancer. UpToDate2006; 14.3. Google Scholar 9 : Fine-needle aspiration of renal masses in adults: analysis of results and diagnostic problems in 108 cases. Diagn Cytopathol1999; 20: 339. Google Scholar 10 : Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol1999; 161: 1470. Link, Google Scholar 11 : Ultrasonically guided fine needle aspiration biopsy of renal masses. J Urol1985; 133: 579. Link, Google Scholar 12 : Percutaneous renal biopsies: accuracy, safety, and indications. Urol Radiol1986; 8: 67. Google Scholar 13 : Renal biopsy-related hemorrhage: frequency and comparison of CT and sonography. J Comput Assist Tomogr1987; 11: 1031. Google Scholar 14 : Renal masses in the adult patient: the role of percutaneous biopsy. Radiology2006; 240: 6. Google Scholar 15 : The posterior intercostal approach for percutaneous renal procedures: risk of puncturing the lung, spleen, and liver as determined by CT. AJR Am J Roentgenol1990; 154: 115. Google Scholar 16 : Diagnostic value of CT-guided biopsy of indeterminate renal masses. Clin Radiol2004; 59: 262. Google Scholar 17 : Role of fine-needle aspiration biopsy in the assessment of renal masses. Diagn Cytopathol1991; 7: 32. Google Scholar 18 : Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol2004; 171: 1802. Link, Google Scholar 19 : Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy: Work in progress. Radiology1992; 183: 509. Google Scholar 20 : Sonographically guided renal mass biopsy: indications and efficacy. J Ultrasound Med2001; 20: 749. Crossref, Medline, Google Scholar 21 : Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol2003; 180: 1281. Google Scholar 22 : Imaging guided biopsies of renal masses. Curr Opin Urol2000; 10: 105. Google Scholar 23 : Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery?. AJR Am J Roentgenol2003; 180: 755. Google Scholar 24 : An update of the Bosniak renal cyst classification system. Urology2005; 66: 484. Google Scholar 25 : Secondary renal neoplasms: an autopsy study. South Med J1979; 72: 806. Google Scholar 26 : Utilization of fine-needle aspiration in the diagnosis of metastatic tumors to the kidney. Diagn Cytopathol1999; 21: 35. Google Scholar 27 : Renal tumors. In: Campbell-Walsh Urology. Edited by . Philadelphia: WB Saunders2007: 2672. chapt 46. Google Scholar 28 : A renal mass in the setting of a nonrenal malignancy: when is a renal tumor biopsy appropriate?. Cancer2004; 101: 2195. Google Scholar 29 : Renal lesions associated with malignant lymphomas. Am J Med1962; 32: 184. Google Scholar 30 : CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management. Eur Radiol2002; 12: 2518. Google Scholar 31 : Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res2005; 11: 3714. Google Scholar 32 : Targeted molecular therapy for renal cell carcinoma. Urology2007; 69: 3. Google Scholar 33 : Nephron-sparing surgery. BJU Int2007; 99: 1245. Google Scholar 34 : Renal tumors in young adults. J Urol2004; 171: 106. Link, Google Scholar 35 : Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol2006; 176: 2391. Link, Google Scholar 36 : The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol2006; 175: 425. Link, Google Scholar 37 : A postoperative prognostic nomogram for renal cell carcinoma. J Urol2001; 166: 63. Link, Google Scholar 38 : A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol2005; 173: 48. Link, Google Scholar 39 : Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol2004; 28: 435. Google Scholar 40 : An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol2002; 168: 2395. Link, Google Scholar 41 : Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res2003; 9: 802. Google Scholar 42 : Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology2005; 66: 1. Google Scholar 43 : Preoperative diagnosis of renal angiomyolipoma: fine needle aspiration cytology and immunocytochemical characterization. Pathology1994; 26: 170. Crossref, Medline, Google Scholar 44 : Fine needle aspiration biopsy of renal cell carcinoma: Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol1993; 37: 367. Google Scholar 45 : Role of percutaneous image-guided biopsy in the evaluation of renal masses. Urol Int2001; 67: 199. Google Scholar 46 : The accuracy of 250 fine needle biopsies of renal tumors. J Urol2005; 174: 44. Link, Google Scholar 47 : Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J Urol2006; 176: 1957. Link, Google Scholar 48 : Techniques, safety and accuracy of needle biopsy of renal tumors. J Urol, suppl2006; 175: 356. abstract 1108. Link, Google Scholar 49 : Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int2007; 99: 290. Google Scholar 50 : Evaluation of sonographically guided percutaneous core biopsy of renal masses. AJR Am J Roentgenol2002; 179: 373. Google Scholar © 2008 by American Urological AssociationFiguresReferencesRelatedDetailsCited byLaguna M (2019) Re: Nephrometry Score Correlated with Tumor Proliferative Activity in T1 Clear Cell Renal Cell CarcinomaJournal of Urology, VOL. 202, NO. 6, (1094-1094), Online publication date: 1-Dec-2019.Lallas C, Scotland K, Zhang M, Schaeffer D, Calvaresi A, Gomella L, Brown D, Shaw C and Trabulsi E (2016) Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral CenterUrology Practice, VOL. 3, NO. 6, (468-474), Online publication date: 1-Nov-2016.Su L, Kuo J, Allan R, Liao J, Ritari K, Tomeny P and Carter C (2015) Fiber-Optic Confocal Laser Endomicroscopy of Small Renal Masses: Toward Real-Time Optical Diagnostic BiopsyJournal of Urology, VOL. 195, NO. 2, (486-492), Online publication date: 1-Feb-2016.Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, Lee F, Ziemlewicz T, Lubner M, Shi F, Nakada S and Abel E (2014) Patient and Tumor Characteristics can Predict Nondiagnostic Renal Mass Biopsy FindingsJournal of Urology, VOL. 193, NO. 6, (1899-1904), Online publication date: 1-Jun-2015.Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen D, Greenberg R, Smaldone M and Kutikov A (2013) Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal BiopsyJournal of Urology, VOL. 191, NO. 2, (296-300), Online publication date: 1-Feb-2014.Ordon M and Landman J (2013) Renal Mass Biopsy: “Just Do It”Journal of Urology, VOL. 190, NO. 5, (1638-1640), Online publication date: 1-Nov-2013.Halverson S, Kunju L, Bhalla R, Gadzinski A, Alderman M, Miller D, Montgomery J, Weizer A, Wu A, Hafez K and Wolf J (2012) Accuracy of Determining Small Renal Mass Management with Risk Stratified Biopsies: Confirmation by Final PathologyJournal of Urology, VOL. 189, NO. 2, (441-446), Online publication date: 1-Feb-2013.Simhan J, Canter D, Sterious S, Smaldone M, Tsai K, Li T, Viterbo R, Chen D, Greenberg R, Kutikov A and Uzzo R (2012) Pathological Concordance and Surgical Outcomes of Sporadic Synchronous Unilateral Multifocal Renal Masses Treated with Partial NephrectomyJournal of Urology, VOL. 189, NO. 1, (43-47), Online publication date: 1-Jan-2013.Millet I, Curros F, Serre I, Taourel P and Thuret R (2012) Can Renal Biopsy Accurately Predict Histological Subtype and Fuhrman Grade of Renal Cell Carcinoma?Journal of Urology, VOL. 188, NO. 5, (1690-1694), Online publication date: 1-Nov-2012.Lee H, Zhou C, Cohen D, Mondelblatt A, Wang Y, Aguirre A, Shen D, Sheikine Y, Fujimoto J and Connolly J (2011) Integrated Optical Coherence Tomography and Optical Coherence Microscopy Imaging of Ex Vivo Human Renal TissuesJournal of Urology, VOL. 187, NO. 2, (691-699), Online publication date: 1-Feb-2012.Heilbrun M, Yu J, Smith K, Dechet C, Zagoria R and Roberts M (2011) The Cost-Effectiveness of Immediate Treatment, Percutaneous Biopsy and Active Surveillance for the Diagnosis of the Small Solid Renal Mass: Evidence From a Markov ModelJournal of Urology, VOL. 187, NO. 1, (39-43), Online publication date: 1-Jan-2012.Breau R, Crispen P, Jenkins S, Blute M and Leibovich B (2010) Treatment of Patients With Small Renal Masses: A Survey of the American Urological AssociationJournal of Urology, VOL. 185, NO. 2, (407-414), Online publication date: 1-Feb-2011.Abel E, Culp S, Matin S, Tamboli P, Wallace M, Jonasch E, Tannir N and Wood C (2010) Percutaneous Biopsy of Primary Tumor in Metastatic Renal Cell Carcinoma to Predict High Risk Pathological Features: Comparison With Nephrectomy AssessmentJournal of Urology, VOL. 184, NO. 5, (1877-1881), Online publication date: 1-Nov-2010.Skolarus T, Serrano M, Grubb R, Katz M, Bullock T, Gao F, Humphrey P and Kibel A (2009) Effect of Reclassification on the Incidence of Benign and Malignant Renal TumorsJournal of Urology, VOL. 183, NO. 2, (455-459), Online publication date: 1-Feb-2010.Jeldres C, Sun M, Liberman D, Lughezzani G, de la Taille A, Tostain J, Valeri A, Cindolo L, Ficarra V, Artibani W, Zigeuner R, Mejean A, Descotes J, Lechevallier E, Mulders P, Perrotte P, Patard J and Karakiewicz P (2009) Can Renal Mass Biopsy Assessment of Tumor Grade be Safely Substituted for by a Predictive Model?Journal of Urology, VOL. 182, NO. 6, (2585-2589), Online publication date: 1-Dec-2009.Crispen P, Boorjian S, Lohse C, Sebo T, Cheville J, Blute M and Leibovich B (2008) Outcomes Following Partial Nephrectomy by Tumor SizeJournal of Urology, VOL. 180, NO. 5, (1912-1917), Online publication date: 1-Nov-2008. Volume 179Issue 1January 2008Page: 20-27 Advertisement Copyright & Permissions© 2008 by American Urological AssociationKeywordskidneycarcinomarenal cellbiopsyepidemiologymoleculardiagnosisMetrics Author Information Brian R. Lane Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author Mary K. Samplaski Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author Brian R. Herts Department of Radiology, Cleveland Clinic, Cleveland, Ohio More articles by this author Ming Zhou Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio More articles by this author Andrew C. Novick Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author Steven C. Campbell Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author Expand All Advertisement PDF downloadLoading ...
Referência(s)